Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-25-000636·STATE STREET CORP
Schedule 13G ownership disclosure
TG THERAPEUTICS INC COM
COMMON STOCK · CUSIP: 88322Q108
Event date: 2025-09-30
- Filing-level shares
- 8,100,619.00
- Percent of class
- 5.1%
- STATE STREET CORPORATION
Shares: 8,100,619.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000636
- Form type
- SCHEDULE 13G
- Filer
- STATE STREET CORP
- CIK
- CIK 93751
- Filed
- Nov 10, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership